 |
PDBsum entry 1jdk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
1jdk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein
|
 |
|
Title:
|
 |
Solution structure of lactam analogue (edap) of HIV gp41 600-612 loop.
|
|
Structure:
|
 |
Acetyl group. Chain: a. Engineered: yes
|
|
Source:
|
 |
Synthetic: yes. Other_details: the parent peptide iwgcsgklictta occurs naturally in HIV gp41 glycoprotein
|
|
NMR struc:
|
 |
25 models
|
 |
|
Authors:
|
 |
A.Phan Chan Du,D.Limal,V.Semetey,H.Dali,M.Jolivet,C.Desgranges, M.T.Cung,J.P.Briand,M.C.Petit,S.Muller
|
Key ref:
|
 |
A.P.Du
et al.
(2002).
Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.
J Mol Biol,
323,
503-521.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Jun-01
|
Release date:
|
01-Jul-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
323:503-521
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.
|
|
A.P.Du,
D.Limal,
V.Semetey,
H.Dali,
M.Jolivet,
C.Desgranges,
M.T.Cung,
J.P.Briand,
M.C.Petit,
S.Muller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The conformational and immunological properties of different analogues
corresponding to the 600-612 disulfide loop of the human immunodeficiency virus
(HIV) gp41 glycoprotein envelope were studied. Fourteen analogues were designed
and synthesised; namely, a series of seven analogues in which the disulfide bond
was replaced by a lactam bridge and a series of seven analogues in which one
residue of each analogue at a time, was replaced by its corresponding
homologised alpha-amino acid (beta(3)-amino acid). In the case of the lactam
analogues, the influence of the two possible CO-NH and NH-CO orientations of the
lactam bridge as well as the size of the lactam ring was explored. The analogues
were tested in ELISA with monoclonal antibodies raised against the 600-612
cyclic parent peptide as well as with sera from HIV-1 infected patients. A
structural analysis of the parent and analogue peptides was carried out in
dimethyl sulfoxide (DMSO-d(6)) using two-dimensional NMR techniques and
molecular dynamics simulations. Comparison of the own conformation of the cyclic
analogues with their either strong or weak reactivity with the antibodies
reveals structural features that may be correlated with the antibody reactivity.
Thus, a close structural similarity, particularly a characteristic orientation
of the side-chains of residues Lys606, Leu607 and Ile608 in the loop, was found
in certain beta(3)-analogues that were better recognised than the parent peptide
by anti-peptide mouse monoclonal antibodies and patients' antibodies.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
|
|
|
| |
The above figure is
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
323,
503-521)
copyright 2002.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.W.Purcell,
J.McCluskey,
and
J.Rossjohn
(2007).
More than one reason to rethink the use of peptides in vaccine design.
|
| |
Nat Rev Drug Discov,
6,
404-414.
|
 |
|
|
|
|
 |
M.A.Rey-Cuillé,
J.Svab,
R.Benferhat,
B.Krust,
J.P.Briand,
S.Muller,
and
A.G.Hovanessian
(2006).
HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
|
| |
J Pharm Pharmacol,
58,
759-767.
|
 |
|
|
|
|
 |
A.G.Hovanessian,
J.P.Briand,
E.A.Said,
J.Svab,
S.Ferris,
H.Dali,
S.Muller,
C.Desgranges,
and
B.Krust
(2004).
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection.
|
| |
Immunity,
21,
617-627.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |